Kymera Therapeutics prices $250.8 million public offering of stock and pre-funded warrants.

From Nasdaq, Inc.: 2025-06-27 19:21:00

Kymera Therapeutics, Inc. (KYMR) has priced a $250.8 million underwritten public offering, including 5,044,500 shares of common stock and 655,500 pre-funded warrants. The deal is priced at $44.00 per share for common stock and $43.9999 for warrants with a nominal exercise price of $0.0001 per share. Underwriters have the option to purchase up to 855,000 additional shares. The offering is expected to close on June 30, 2025. Kymera plans to use the proceeds for developing degrader programs and general corporate purposes. KYMR closed at $44.12 on Friday, down 3.48% on the NasdaqGM.



Read more at Nasdaq, Inc.: Kymera Prices $250.8 Mln Public Offering Of Stock And Pre-Funded Warrants